Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
59.43
+2.47 (4.34%)
Jul 7, 2026, 11:51 AM EDT - Market open
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.58 billion as of July 7, 2026. Its market cap has increased by 102.38% in one year.
Market Cap
8.58B
Enterprise Value
6.89B
1-Year Change
102.38%
Ranking
Category
Stock Price
$59.43
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.58B, an increase of 521.87%. That is a compound annual growth rate of 35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 8.58B | 42.08% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 9.77B |
| Corcept Therapeutics | 9.68B |
| Halozyme Therapeutics | 9.42B |
| Kymera Therapeutics | 9.34B |
| Praxis Precision Medicines | 8.88B |
| Protagonist Therapeutics | 8.46B |
| Immunovant | 7.96B |
| Rhythm Pharmaceuticals | 7.82B |